541 related articles for article (PubMed ID: 34597748)
1. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery carriers on the fringes: natural red blood cells versus synthetic multilayered capsules.
Muzykantov VR
Expert Opin Drug Deliv; 2013 Jan; 10(1):1-4. PubMed ID: 23176316
[TBL] [Abstract][Full Text] [Related]
3. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
Pan D; Vargas-Morales O; Zern B; Anselmo AC; Gupta V; Zakrewsky M; Mitragotri S; Muzykantov V
PLoS One; 2016; 11(3):e0152074. PubMed ID: 27003833
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
Bhateria M; Rachumallu R; Singh R; Bhatta RS
Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery by erythrocytes: "Primum non nocere".
Villa CH; Seghatchian J; Muzykantov V
Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
[TBL] [Abstract][Full Text] [Related]
8. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
[TBL] [Abstract][Full Text] [Related]
9. Red Blood Cells as Smart Delivery Systems.
Han X; Wang C; Liu Z
Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
[TBL] [Abstract][Full Text] [Related]
10. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin.
Malhotra S; Dumoga S; Sirohi P; Singh N
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22141-22151. PubMed ID: 31148443
[TBL] [Abstract][Full Text] [Related]
13. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
14. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
Tagami T; Ozeki T
J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude.
Brenner JS; Pan DC; Myerson JW; Marcos-Contreras OA; Villa CH; Patel P; Hekierski H; Chatterjee S; Tao JQ; Parhiz H; Bhamidipati K; Uhler TG; Hood ED; Kiseleva RY; Shuvaev VS; Shuvaeva T; Khoshnejad M; Johnston I; Gregory JV; Lahann J; Wang T; Cantu E; Armstead WM; Mitragotri S; Muzykantov V
Nat Commun; 2018 Jul; 9(1):2684. PubMed ID: 29992966
[TBL] [Abstract][Full Text] [Related]
16. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
Brenner JS; Mitragotri S; Muzykantov VR
Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
Pathak K; Keshri L; Shah M
Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte-inspired delivery systems.
Hu CM; Fang RH; Zhang L
Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
[TBL] [Abstract][Full Text] [Related]
19. Mutual interaction of red blood cells influenced by nanoparticles.
Avsievich T; Popov A; Bykov A; Meglinski I
Sci Rep; 2019 Mar; 9(1):5147. PubMed ID: 30914741
[TBL] [Abstract][Full Text] [Related]
20. Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation.
Zhu K; Xu Y; Zhong R; Li W; Wang H; Wong YS; Venkatraman S; Liu J; Cao Y
Regen Biomater; 2023; 10():rbad045. PubMed ID: 37250975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
